Related Experiment Video
Updated: Jun 26, 2026

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Age-related differences in the pathogenesis of calcific aortic stenosis: the potential role of resistin
Dania Mohty1, Philippe Pibarot, Jean-Pierre Després
1Laboratoire d'Etudes Moléculaires des Valvulopathies, Groupe de Recherche en Valvulopathies, Quebec Heart Institute/Hôpital Laval Research Center, Department of Surgery, Laval University, Quebec, Canada.
Insights
Elderly patients with aortic stenosis have less atherogenic lipid profiles but higher resistin levels, which correlate with valve calcification and inflammation, suggesting age-related factors beyond lipids contribute to AS.
Area of Science:
- Cardiovascular Medicine
- Metabolic Research
- Geriatric Cardiology
Background:
- Aortic stenosis (AS) is linked to atherosclerosis, but its pathophysiology in the elderly remains unclear.
- Investigating age-specific metabolic determinants of valvular inflammation and calcification in AS is crucial.
Purpose of the Study:
- To compare the metabolic profiles of elderly and younger patients with severe aortic stenosis.
- To determine the association between plasma adipokines, lipid profiles, and valvular characteristics in elderly AS patients.
Main Methods:
- Analyzed plasma lipid profiles and adipokine levels (resistin, leptin) in 114 patients undergoing aortic stenosis surgery.
- Quantified aortic valve calcification and inflammation in relation to metabolic markers.
Main Results:
- Elderly patients (>70 years) exhibited lower LDL-C, reduced small LDL particles, and larger HDL particle size.
- Increased plasma resistin and leptin levels were observed in elderly patients compared to younger ones.
- Higher plasma resistin correlated significantly with increased aortic valve calcification and inflammation in the elderly.
Conclusions:
- The lipid profile in elderly AS patients is less atherogenic than in middle-aged individuals.
- Elevated resistin levels in older adults with AS are associated with valvular calcification and inflammation.
- Age-related changes in resistin may play a role in the development of aortic stenosis, independent of traditional lipid-driven atherosclerosis.
Background:
Aortic stenosis (AS) is considered as an atherosclerotic related process. However, there are uncertainties whether AS in the elderly is associated with the same pathophysiological processes as in younger patients. We hypothesized that the metabolic determinants of the valvular inflammatory and calcifying processes occurring in elderly patients are different from those observed earlier in life.
Methods:
Among 114 patients operated for a severe AS, a complete plasma lipid blood profile and plasma levels of adipokines (resistin, leptin) were determined. The calcium content of the aortic valve was measured and valvular inflammation was quantified.
Results:
Elderly patients (>or=70 years) had significantly lower LDL-C (p=0.02), lower LDL-C associated with small size particles (LDL-C <255 A) (p=0.003), and higher HDL peak particle size than younger patients (p=0.03). In addition, elderly patients had increased plasma leptin (p=0.04) and resistin (p=0.0004) levels compared to the middle-aged group (<70 years). In the elderly patients, higher plasma resistin blood levels were associated with increased valve calcium content and inflammation.
Conclusion:
The lipid profile of elderly patients was found less atherogenic than that of middle-aged patients. On the other hand, older patients with AS had higher plasma level of resistin which was associated with the degree of valvular calcification and inflammation. These results suggest that, beyond lipid model of atherosclerosis, age-related processes affecting resistin blood levels may also be involved in the late development of AS.
Related Concept Videos
Atherosclerosis I: Introduction
Mitral Stenosis I: Introduction
Aortic Regurgitation I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Rheumatic Heart Disease I: Introduction

